Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 17/04/2018

Debbie Rigby takes a look at the latest in research news Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes A large UK-based cohort study has shown the use of dipeptidyl peptidase-4 inhibitors is associated with an increased risk of inflammatory bowel disease in patients with type 2 diabetes.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Why not fund that pharmacist to become a doctor?’

They already sold their souls to fatten their bank accounts decades ago. Every penny counts for them and ticking boxes…

L L

‘Why not fund that pharmacist to become a doctor?’

60DD doesn’t mean demand will drop. It just means the money will reduce. The need for us will still be…

John Smith

Queensland commences shift towards ‘fuller scope of practice’

It is scary that the QLD gov has caved in to the whims and desire of the PGA. What concerns…

Morbidly Obese John

Pharmacist who ‘could barely stand’ while working drunk appeals decision

Showing empathy and helping the person find the support they need to recover is the best approach. It is important…

(Mary) Kay Dunkley

Research Roundup

Previous Unseasonal conditions

Next App helps compliance, but not blood pressure

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Unseasonal conditions

Next App helps compliance, but not blood pressure

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.